Highlights from the 2014 LA Auto Show

Vaccines

An Ebola vaccine delivered through the nose and into the airways could help reduce the spr...

Scientists have produced a single dose Ebola vaccine shown to provide primates with long-term protection from the deadly disease. What is most promising about the development is the delivery method, with the vaccine administered through the nose and lungs, mitigating the associated risk of spreading the disease through infected needles.  Read More

The new vaccine’s active ingredient comes from hookworms themselves, a protein from a comm...

A clinical trial of a permanent vaccine for hookworm has been completed in Brazil, giving hope for a permanent end to a problem that affects 600 million people worldwide. US-based Sabin Vaccine Institute, which has developed the vaccine has called hookworm "one of the most pervasive neglected tropical diseases (NTD) affecting the world’s poor."  Read More

Dr. Anne Moore displays the microneedle patch

Scientists at University College Cork in Ireland have successfully finished pre-clinical testing of an experimental vaccine against malaria delivered through the skin. The method is an improvement on this type of vaccine delivery, whose use is being researched in relation to other infections as well, including Ebola and HIV.  Read More

Newly-developed nasal spray vaccines offer some key advantages over injections  (Photo: Sh...

Vaccines save lives, but sometimes they fail to reach the people who need them most, in parts of the developing world. A research team from Iowa State University is currently developing a new generation of vaccines that uses nanotechnology, and is delivered in spray form. One of the advantages of this new type of vaccine is that is can increase access to people living in remote areas because it requires no refrigeration and is simpler to administer.  Read More

New technology could allow vaccines to be produced when and where they're needed (Photo: S...

Researchers from the University of Washington have created a vaccine with the potential to make on-demand vaccination cheaper and quicker, using engineered nanoparticles. Tests with mice show definite promise for the technology's use on humans.  Read More

Scientists at the Oregon Health and Science University have announced a positive step towa...

A very promising vaccine candidate for HIV/AIDS has shown the ability to completely clear the simian immunodeficiency virus (SIV), a very aggressive form of HIV that leads to AIDS in monkeys. Developed at the Vaccine and Gene Therapy Institute at the Oregon Health and Science University (OHSU), the vaccine proved successful in about fifty percent of the subjects tested and could lead to a human vaccine preventing the onset of HIV/AIDS and even cure patients currently on anti-retroviral drugs.  Read More

Scientists have used microneedle arrays to store a live vaccine at room temperature, and a...

While it’s vitally important to bring vaccines for diseases such as tuberculosis to developing nations, getting them there is only part of the challenge. Because these countries often have unreliable infrastructures, it’s entirely possible that the vaccines can’t consistently be kept as cold as is required. As a result, they could be rendered ineffective. Now, however, scientists from King’s College London have succeeded in containing a dried live vaccine in a microneedle array, that doesn’t need to be refrigerated.  Read More

A conceptual image of the vaccine patch developed at MIT that could enable the use of DNA ...

Taking a two-month-old in for vaccination shots and watching them get stuck with six needles in rapid succession can be painful for child and parent alike. If the work of an MIT team of researchers pans out, those needles may be thing of the past thanks to a new dissolvable polymer film that allows the vaccination needle to be replaced with a patch. This development will not only make vaccinations less harrowing, but also allow for developing and delivering vaccines for diseases too dangerous for conventional techniques.  Read More

Tobacco plants used in the development of the vaccine

A familiar news topic during the flu season is the difficulties that the authorities face in producing enough flu vaccine fast enough to control the outbreak. That’s a serious enough problem, but when the influenza outbreak turns out to be the start of a global pandemic, then hundreds of millions of lives could be at risk. To combat this, the Defense Advanced Research Projects Agency (DARPA) has developed a new way of making vaccines that has turned out 10 million doses of H1N1 influenza vaccine in a month, in a recent test run.  Read More

Methamphetamine addicts may one day be able to receive a vaccine, that keeps them from get...

Methamphetamine is one of the most addictive and thus commonly-used street drugs – according to the United Nations Office on Drugs and Crime, there are currently nearly 25 million meth addicts worldwide. Help may be on the way, however. Scientists from The Scripps Research Institute have had success in using a methamphetamine vaccine to block the effects on meth on lab rats.  Read More

Looking for something? Search our 29,485 articles